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-Jordan Hupert, MD
Hypertonic saline for bronchiolitis -a metaanalysis reanalysis 
Main Results
Two main sources of heterogeneity were identified. Controlling, either for one study population with a widely divergent primary outcome definition, or, for divergent, between-treatment-groups prepresentation mean day of illness (DOI), resolved the heterogeneity: I 2 reduced from 78% to 45% and 0%, respectively, and produced nonsignificant summary estimates (ie, HS does not affect LOS). Conclusions An outlier population and unbalanced treatment groups confounded previous HS meta-analyses' results. Commentary The substantial heterogeneity of LOS could be expected given the variation across trials in definition of acute bronchiolitis, disease severity, standard care, intervention regimen, outcome measures and risk of bias. This and other recently published systematic reviews have explored such potential heterogeneity sources. [1] [2] [3] One of the main sources of heterogeneity identified by this review was the outlier results of two trials from the same group in China. These two trials used more stringent discharge criteria and had longer LOS in the control groups. Another main source of heterogeneity identified by this review was an imbalance in the mean DOI at presentation between treatment groups. However, caution should be taken in interpreting this finding. First, a difference of 0.5-day in DOI is an arbitrary cut-off for classifying subgroups. Any changes in the cut-off value may substantially affect the results of analysis. Second, it does not seem reasonable to combine, into the same subgroup, five trials that did not report DOI, two trials with a group difference of ≥0.5 day in DOI, and three trials with a balanced DOI. Given that neither individual trials nor pooled estimates from systematic reviews could definitively confirm or deny the potential benefits of HS in acute bronchiolitis, large international multicenter trials are still warranted. Commentary Historically, uncomplicated skin-abscess firstline treatment has been surgical drainage, resulting in resolution in approximately 80% of cases. 1 Treatment with antibiotics, both compared with drainage alone and concomitant drainage plus antibiotics, has not been previously shown to improve cure rates. However, many of these studies were performed prior to increasing rates of community acquired MRSA and limited by small patient populations.
Linjie Zhang, MD, PhD
1,2 The current study by Talan et al, which is both well-designed and adequately powered, provides new evidence as to the efficacy of adjuvant antibiotic treatment of skin abscesses. These results should be interpreted with caution, as a significant number of abscesses (73.6%) were cured with drainage alone. Improvements in cure rate, new infections, and repeat drainage were modest. Gastrointestinal side effects of antibiotics treatment were mild and there were no serious adverse events, such as Clostridium difficile colitis or Stevens Johnson syndrome. This study, in conjunction with another study, 3 suggests the cost-benefit ratio for antibiotics in the treatment of soft tissue infections may be changing.
James Antoon, MD, PhD University of Illinois at Chicago
Chicago, Illinois Commentary This meta-analysis is meticulously performed and introduces both Grading of Recommendations Assessment, Development and Evaluation for assessing the quality of evidence, and the Clavien-Dindo classification for stratification of complications. Surprisingly, there are now more metaanalyses published than randomized controlled trials, and even a review of the meta-analyses. 1 All meta-analyses include a different combination of studies but come to fairly similar conclusions, raising the question of the benefit of yet another metaanalysis. That said, this meta-analysis provides the best presented, and probably best quality data to present to the individual patient for shared decision-making. Still, long-term outcome data are needed to reach a final conclusion regarding the benefit of the nonoperative approach to acute appendicitis. My personal opinion is that the antibiotics-first, appendectomy-when-needed treatment strategy of nonperforated acute appendicitis in children is valid in cases where surgery, and general anesthesia, would mean an increased risk (eg, post gastroschisis, omphalocele, or other previous major abdominal surgery, ongoing airway infection, and in patients with cystic fibrosis). Apart from this, nonoperative treatment should not routinely be performed outside the framework of a randomized controlled trial. Main Results Children receiving late PN had fewer new infections, number needed to treat (NNT) 13 (95% CI, 9-24), and less PICU-level care (>1week), NNT 8 (95% CI, 6-11). Conclusions Providing critically ill children PN only after 1 week was clinically superior to early nutrition. Commentary The Early versus Late Parenteral Nutrition in the Pediatric Intensive Care Unit (PEPaNIC) Study was a 3-center trial that compared early (within 24 hours) versus late (day 8) supplemental PN in the PICU population. The patient selection criteria and the unique PN strategies limit the external validity of this elegant study. Early or late PN strategy was randomly allocated to patients who tolerated early enteral nutrition with stepwise advancement, but were unable to reach 80% of the energy goal within 24 hours of admission. Most US centers do not routinely practice the aggressive PN strategy in the early group. 1 Furthermore, only a fraction of patients in the late arm received any PN. The energy goals were equation-estimated in 2 of the 3 sites, with potential for underfeeding and overfeeding. 2 Based on the PEPaNIC Study results, the routine use of PN within 24 hours of PICU admission cannot be recommended. These results cannot be extrapolated to severely malnourished patients, low birth weight newborns, and those ineligible for any enteral nutrition. These vulnerable groups were inadequately represented in the study and may not benefit from prolonged nutrient deprivation. Individualized macronutrient goals and emphasis on the enteral route with selective and cautious PN use might be prudent in the PICU.
